TrueBinding is an early-stage biotherapeutics development company that focuses on creating new and exciting molecules for applications.
TrueBinding has raised $57.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
TrueBinding's investors include ChinaNetCenter.
TrueBinding is headquartered in Menlo Park, United States.
TrueBinding is an early-stage biotherapeutics development company that focuses on creating new and exciting molecules for applications.
TrueBinding is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TrueBinding — Funding & Investors." VCBacked, July 5, 2023, https://www.vcbacked.co/company/truebinding. Accessed August 14, 2026.
VCBacked. (2023). TrueBinding — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/truebinding
{{cite web |title=TrueBinding — Funding & Investors |url=https://www.vcbacked.co/company/truebinding |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated